ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2025

A brain-penetrant bispecific antibody lowers oligomeric alpha-synuclein and activates microglia in a mouse model of alpha-synuclein pathology.

Dag Sehlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.